...
首页> 外文期刊>Iranian journal of public health. >Tetra-Primer ARMS PCR Optimization for Detection of IVS-II-I (G-A) and FSC 8/9 InsG Mutations in β-Thalassemia Major Patients in Isfahan Population
【24h】

Tetra-Primer ARMS PCR Optimization for Detection of IVS-II-I (G-A) and FSC 8/9 InsG Mutations in β-Thalassemia Major Patients in Isfahan Population

机译:四联引物ARMS PCR优化检测伊斯法罕人群中β-地中海贫血患者的IVS-II-I(G-A)和FSC 8/9 InsG突变

获取原文

摘要

Background:β-thalassemia, a monogenic autosomal recessive disorder, is prevalent in Middle East, particularly in Iran. In Iran, near to 20 mutations in the β-globin gene are introduced as common mutations with varying incidence frequencies in each city. Therefore, detection and screening for couples at high risk can help to solve the problems of this disease. In this study, optimized genotyping of two common mutations in Isfahan Province, IVSII-I (G-A) and FSC-8/9 insG, was performed using the T-ARMS method.Methods:In this case-control study, 10 healthy individuals and 30 patients affected by β-thalassemia major with a mean 24.76 ± 4.5 years were selected from Omid Hospital in Isfahan Province. After designing tetra primers for two prevalent mutations IVSII-I (G-A) and FSC-8/9 insG, samples were genotyped using tetra-primers ARMS PCR technique.Results:We have developed a sensitive single tube tetra-primers PCR assay to detect both IVSII-1 (G-A) and FS8-9 insG mutations. Moreover, we have distinguished homozygous and heterozygous forms of these mutations successfully. The frequency of IVSII-1 (G-A) mutation from 30 patients in Isfahan was 86.6% (33.3% heterozygote, and 53.3% mutant homozygote) and for FS8-9 insG mutation was 16.6% (13.3% heterozygote, and 3.3% mutant homozygote).Conclusion:Tetra-primers ARMS PCR could be a reliable, accurate and simple technique for genotyping SNP and different mutations. So far, no study was done on optimization methods for genotyping mutations in β-thalassemia by T-ARMS. Here, we successfully adjusted and enhanced this method for recognizing two common mutations (FSC-8/9 insG and IVSII-I (G-A)) of β-thalassemia in Isfahan population.
机译:背景:β-地中海贫血是一种单基因常染色体隐性遗传疾病,在中东尤其是伊朗非常普遍。在伊朗,每个城市都会引入近20种β-珠蛋白基因突变作为常见突变,且其发生频率各不相同。因此,对高危夫妇的检测和筛查可以帮助解决这种疾病的问题。在本研究中,使用T-ARMS方法对伊斯法罕省的两个常见突变IVSII-I(GA)和FSC-8 / 9 insG进行了优化的基因分型。从伊斯法罕省的奥米德医院(Omid Hospital)选择30例受重度β地中海贫血影响的患者,平均年龄为24.76±4.5岁。在设计了两个常见突变IVSII-I(GA)和FSC-8 / 9 insG的四引物后,使用四引物ARMS PCR技术对样品进行了基因分型。结果:我们开发了一种灵敏的单管四引物PCR检测法IVSII-1(GA)和FS8-9 insG突变。此外,我们已经成功地区分了这些突变的纯合和杂合形式。来自伊斯法罕的30位患者的IVSII-1(GA)突变的频率为86.6%(杂合子为33.3%,突变纯合子为53.3%),而FS8-9 insG突变的频率为16.6%(杂合子为13.3%,突变纯合子为3.3%)。结论:四引物ARMS PCR技术可作为对SNP和不同突变进行基因分型的可靠,准确和简单的技术。到目前为止,尚未有关于通过T-ARMS优化β地中海贫血基因型突变的方法的研究。在这里,我们成功地调整和增强了该方法,以识别伊斯法罕人群中β地中海贫血的两个常见突变(FSC-8 / 9 insG和IVSII-I(G-A))。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号